| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.2 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.06 |